Acute caffeine mouth rinsing does not improve 10-km running performance in CYP1A2 C-allele carriers

Detalhes bibliográficos
Autor(a) principal: Figueiredo, Nayra
Data de Publicação: 2021
Outros Autores: Queiroz, Marcela, Felicio, Fernanda P., Ferreira, Jessica, Gerosa-Neto, Jose [UNESP], Mota, Jo Ao F., Silva, Christielly R. da, Ghedini, Paulo C., Saunders, Bryan, Pimentel, Gustavo D.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1016/j.clnesp.2021.02.012
http://hdl.handle.net/11449/210156
Resumo: Purpose: This study assessed whether caffeine mouth rinsing affects 10-km run performance and vertical jump in recreational runners. Methods: A double-blind, placebo-controlled, crossover study was conducted. Ten well-trained volunteers performed two trials, following caffeine or placebo mouth rinse, separated by seven days. Immediately before the 10-km run, a 10-second mouth rinse with either 300 mg of caffeine (1.2%) or microcrystalline cellulose (placebo) diluted in 25 mL of water was performed. Pre- and post-exercise, participants performed a vertical jump test. A Garmin Forerunner (R) GPS, was used to measure 10-km running time and an 11-point Borg scale was used post-exercise to measure ratings of perceived exertion. Blood samples were also collected during the visit in the laboratory in the afternoon period to classify individuals according to their CYP1A2 genotype. Vertical jump performance was evaluated using a force plate. Results: Nine runners (90%) were CC homozygotes and one (10%) was an AC heterozygote for CYP1A2. There was no difference in 10-km time-trial performance (Placebo: 47.07 +/- 5.18 vs. CAF: 47.45 +/- 6.34 min, p = 0.89), ratings of perceived exertion (Placebo: 17 +/- 1 vs. CAF: 16 +/- 2, p = 0.34) or vertical jump power (Placebo, Pre: 4.5 +/- 0.6 W.kg-1 and Post: 4.5 +/- 0.7 W.kg-1; CAF: Pre: 4.4 +/- 0.7 W.kg-1 and Post: 4.4 +/- 0.8 W.kg-1, d = 0.21, p = 0.66) between trials. Conclusion: Acute caffeine mouth rinsing (1.2%) did not improve 10-km performance and showed similar null effects on vertical jump performance in CYP1A2 C-allele carriers. (C) 2021 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.
id UNSP_4b50465eb4117d849c60f72b14c66422
oai_identifier_str oai:repositorio.unesp.br:11449/210156
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Acute caffeine mouth rinsing does not improve 10-km running performance in CYP1A2 C-allele carriersCaffeineCYP1A2Mouth rinseRunningGenotypeErgogenic aidPurpose: This study assessed whether caffeine mouth rinsing affects 10-km run performance and vertical jump in recreational runners. Methods: A double-blind, placebo-controlled, crossover study was conducted. Ten well-trained volunteers performed two trials, following caffeine or placebo mouth rinse, separated by seven days. Immediately before the 10-km run, a 10-second mouth rinse with either 300 mg of caffeine (1.2%) or microcrystalline cellulose (placebo) diluted in 25 mL of water was performed. Pre- and post-exercise, participants performed a vertical jump test. A Garmin Forerunner (R) GPS, was used to measure 10-km running time and an 11-point Borg scale was used post-exercise to measure ratings of perceived exertion. Blood samples were also collected during the visit in the laboratory in the afternoon period to classify individuals according to their CYP1A2 genotype. Vertical jump performance was evaluated using a force plate. Results: Nine runners (90%) were CC homozygotes and one (10%) was an AC heterozygote for CYP1A2. There was no difference in 10-km time-trial performance (Placebo: 47.07 +/- 5.18 vs. CAF: 47.45 +/- 6.34 min, p = 0.89), ratings of perceived exertion (Placebo: 17 +/- 1 vs. CAF: 16 +/- 2, p = 0.34) or vertical jump power (Placebo, Pre: 4.5 +/- 0.6 W.kg-1 and Post: 4.5 +/- 0.7 W.kg-1; CAF: Pre: 4.4 +/- 0.7 W.kg-1 and Post: 4.4 +/- 0.8 W.kg-1, d = 0.21, p = 0.66) between trials. Conclusion: Acute caffeine mouth rinsing (1.2%) did not improve 10-km performance and showed similar null effects on vertical jump performance in CYP1A2 C-allele carriers. (C) 2021 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Univ Fed Goias, Fac Nutr, Clin & Sports Nutr Res Lab, Goiania, Go, BrazilUniv Estadual Paulista, Dept Phys Educ, Exercise & Immunometab Res Grp, Presidente Prudente, BrazilUniv Fed Goias, Inst Biol Sci, Goiania, Go, BrazilUniv Sao Paulo, Fac Med FMUSP, Sch Phys Educ & Sport, Appl Physiol & Nutr Res Grp,Rheumatol Div, Sao Paulo, SP, BrazilUniv Sao Paulo, Fac Med FMUSP, Inst Orthoped & Traumatol, Sao Paulo, BrazilUniv Estadual Paulista, Dept Phys Educ, Exercise & Immunometab Res Grp, Presidente Prudente, BrazilFAPESP: 2016/50438-0Elsevier B.V.Universidade Federal de Goiás (UFG)Universidade Estadual Paulista (Unesp)Universidade de São Paulo (USP)Figueiredo, NayraQueiroz, MarcelaFelicio, Fernanda P.Ferreira, JessicaGerosa-Neto, Jose [UNESP]Mota, Jo Ao F.Silva, Christielly R. daGhedini, Paulo C.Saunders, BryanPimentel, Gustavo D.2021-06-25T12:41:23Z2021-06-25T12:41:23Z2021-04-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article93-97http://dx.doi.org/10.1016/j.clnesp.2021.02.012Clinical Nutrition Espen. Amsterdam: Elsevier, v. 42, p. 93-97, 2021.2405-4577http://hdl.handle.net/11449/21015610.1016/j.clnesp.2021.02.012WOS:000632863600010Web of Sciencereponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengClinical Nutrition Espeninfo:eu-repo/semantics/openAccess2024-06-18T17:43:00Zoai:repositorio.unesp.br:11449/210156Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T21:47:27.024653Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Acute caffeine mouth rinsing does not improve 10-km running performance in CYP1A2 C-allele carriers
title Acute caffeine mouth rinsing does not improve 10-km running performance in CYP1A2 C-allele carriers
spellingShingle Acute caffeine mouth rinsing does not improve 10-km running performance in CYP1A2 C-allele carriers
Figueiredo, Nayra
Caffeine
CYP1A2
Mouth rinse
Running
Genotype
Ergogenic aid
title_short Acute caffeine mouth rinsing does not improve 10-km running performance in CYP1A2 C-allele carriers
title_full Acute caffeine mouth rinsing does not improve 10-km running performance in CYP1A2 C-allele carriers
title_fullStr Acute caffeine mouth rinsing does not improve 10-km running performance in CYP1A2 C-allele carriers
title_full_unstemmed Acute caffeine mouth rinsing does not improve 10-km running performance in CYP1A2 C-allele carriers
title_sort Acute caffeine mouth rinsing does not improve 10-km running performance in CYP1A2 C-allele carriers
author Figueiredo, Nayra
author_facet Figueiredo, Nayra
Queiroz, Marcela
Felicio, Fernanda P.
Ferreira, Jessica
Gerosa-Neto, Jose [UNESP]
Mota, Jo Ao F.
Silva, Christielly R. da
Ghedini, Paulo C.
Saunders, Bryan
Pimentel, Gustavo D.
author_role author
author2 Queiroz, Marcela
Felicio, Fernanda P.
Ferreira, Jessica
Gerosa-Neto, Jose [UNESP]
Mota, Jo Ao F.
Silva, Christielly R. da
Ghedini, Paulo C.
Saunders, Bryan
Pimentel, Gustavo D.
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Federal de Goiás (UFG)
Universidade Estadual Paulista (Unesp)
Universidade de São Paulo (USP)
dc.contributor.author.fl_str_mv Figueiredo, Nayra
Queiroz, Marcela
Felicio, Fernanda P.
Ferreira, Jessica
Gerosa-Neto, Jose [UNESP]
Mota, Jo Ao F.
Silva, Christielly R. da
Ghedini, Paulo C.
Saunders, Bryan
Pimentel, Gustavo D.
dc.subject.por.fl_str_mv Caffeine
CYP1A2
Mouth rinse
Running
Genotype
Ergogenic aid
topic Caffeine
CYP1A2
Mouth rinse
Running
Genotype
Ergogenic aid
description Purpose: This study assessed whether caffeine mouth rinsing affects 10-km run performance and vertical jump in recreational runners. Methods: A double-blind, placebo-controlled, crossover study was conducted. Ten well-trained volunteers performed two trials, following caffeine or placebo mouth rinse, separated by seven days. Immediately before the 10-km run, a 10-second mouth rinse with either 300 mg of caffeine (1.2%) or microcrystalline cellulose (placebo) diluted in 25 mL of water was performed. Pre- and post-exercise, participants performed a vertical jump test. A Garmin Forerunner (R) GPS, was used to measure 10-km running time and an 11-point Borg scale was used post-exercise to measure ratings of perceived exertion. Blood samples were also collected during the visit in the laboratory in the afternoon period to classify individuals according to their CYP1A2 genotype. Vertical jump performance was evaluated using a force plate. Results: Nine runners (90%) were CC homozygotes and one (10%) was an AC heterozygote for CYP1A2. There was no difference in 10-km time-trial performance (Placebo: 47.07 +/- 5.18 vs. CAF: 47.45 +/- 6.34 min, p = 0.89), ratings of perceived exertion (Placebo: 17 +/- 1 vs. CAF: 16 +/- 2, p = 0.34) or vertical jump power (Placebo, Pre: 4.5 +/- 0.6 W.kg-1 and Post: 4.5 +/- 0.7 W.kg-1; CAF: Pre: 4.4 +/- 0.7 W.kg-1 and Post: 4.4 +/- 0.8 W.kg-1, d = 0.21, p = 0.66) between trials. Conclusion: Acute caffeine mouth rinsing (1.2%) did not improve 10-km performance and showed similar null effects on vertical jump performance in CYP1A2 C-allele carriers. (C) 2021 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.
publishDate 2021
dc.date.none.fl_str_mv 2021-06-25T12:41:23Z
2021-06-25T12:41:23Z
2021-04-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1016/j.clnesp.2021.02.012
Clinical Nutrition Espen. Amsterdam: Elsevier, v. 42, p. 93-97, 2021.
2405-4577
http://hdl.handle.net/11449/210156
10.1016/j.clnesp.2021.02.012
WOS:000632863600010
url http://dx.doi.org/10.1016/j.clnesp.2021.02.012
http://hdl.handle.net/11449/210156
identifier_str_mv Clinical Nutrition Espen. Amsterdam: Elsevier, v. 42, p. 93-97, 2021.
2405-4577
10.1016/j.clnesp.2021.02.012
WOS:000632863600010
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Clinical Nutrition Espen
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 93-97
dc.publisher.none.fl_str_mv Elsevier B.V.
publisher.none.fl_str_mv Elsevier B.V.
dc.source.none.fl_str_mv Web of Science
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1808129358446985216